Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (281-290 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1993
Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patientsP Bacher, B Horst, H G Breyer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Procoagulant and anticoagulant effects of intravascular contrast media as assessed by thromboelastographyO Iqbal, W Jeske, D Hoppensteadt, et al.
Biochemistry|December 15, 1992
Isolation and characterization of human heparinR J Linhardt, S A Ampofo, J Fareed, et al.
International Angiology : a Journal of the International Union of Angiology|March 15, 2005
Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysisM Florian-Kujawski, W Hussain, B Chyna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Comparative tissue factor pathway inhibitor release potential of heparinsM Tobu, Q Ma, O Iqbal, et al.
Investigative Radiology|February 1, 1995
Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudinM J Koza, T C Shankey, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiationW Jeske, O Iqbal, S Gonnela, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit modelT Hubbard, T Olivier, P Bacher, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplastyJ Fareed, J M Walenga, F Leya, et al.
Pageof 39

Showing results (281-290 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|January 1, 1993
Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patientsP Bacher, B Horst, H G Breyer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Procoagulant and anticoagulant effects of intravascular contrast media as assessed by thromboelastographyO Iqbal, W Jeske, D Hoppensteadt, et al.
Biochemistry|December 15, 1992
Isolation and characterization of human heparinR J Linhardt, S A Ampofo, J Fareed, et al.
International Angiology : a Journal of the International Union of Angiology|March 15, 2005
Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysisM Florian-Kujawski, W Hussain, B Chyna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Comparative tissue factor pathway inhibitor release potential of heparinsM Tobu, Q Ma, O Iqbal, et al.
Investigative Radiology|February 1, 1995
Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudinM J Koza, T C Shankey, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiationW Jeske, O Iqbal, S Gonnela, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit modelT Hubbard, T Olivier, P Bacher, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplastyJ Fareed, J M Walenga, F Leya, et al.
Pageof 39